Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
作者： Adnan Yaqoob , Aamer Ali Khattak , Muhammad Faisal Nadeem , Huma Fatima , Gillian Mbambo
DOI: 10.1186/S12936-018-2620-Y
关键词:
摘要: Background In Pakistan, artesunate (AS) in combination with sulfadoxine–pyrimethamine (SP) is the recommended treatment for uncomplicated Plasmodium falciparum malaria. Monitoring molecular markers of anti-malarial drug resistance crucial early detection and containment parasite to treatment. Currently, no data are available on artemisinin (K13 mutations) P. isolates from Pakistan. In this study, prevalence mutations associated SP was estimated different regions
biomedcentral.com
springer.com
sci-hub.se 参考文章(50)
G. Q. Zhang, Y. Y. Guan, B. Zheng, S. Wu, L. H. Tang, Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China Tropical Medicine & International Health. ,vol. 14, pp. 1266- 1271 ,(2009) , 10.1111/J.1365-3156.2009.02342.X
Christopher V. Plowe, Abdoulaye Djimde, Madama Bouare, Ogobara Doumbo, Thomas E. Wellems, Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa American Journal of Tropical Medicine and Hygiene. ,vol. 52, pp. 565- 568 ,(1995) , 10.4269/AJTMH.1995.52.565
Agathe Boussaroque, Bécaye Fall, Marylin Madamet, Cheikhou Camara, Nicolas Benoit, Mansour Fall, Aminata Nakoulima, Pierre Dionne, Kadidiatou Ba Fall, Bakary Diatta, Yaya Diémé, Boubacar Wade, Bruno Pradines, None, Emergence of mutations in the K13 Propeller gene of Plasmodium falciparum isolates from Dakar, Senegal in 2013-2014 Antimicrobial Agents and Chemotherapy. ,vol. 60, pp. 624- 627 ,(2016) , 10.1128/AAC.01346-15
Mandana Afsharpad, Sedigheh Zakeri, Sakineh Pirahmadi, Navid Dinparast Djadid, Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran. Acta Tropica. ,vol. 121, pp. 13- 18 ,(2012) , 10.1016/J.ACTATROPICA.2011.09.010
D. S. Peterson, W. K. Milhous, T. E. Wellems, Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 3018- 3022 ,(1990) , 10.1073/PNAS.87.8.3018
S.A. Omar, I.S. Adagu, D.C. Warhurst, Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Transactions of The Royal Society of Tropical Medicine and Hygiene. ,vol. 95, pp. 315- 319 ,(2001) , 10.1016/S0035-9203(01)90250-0
J.Werner Zolg, James R. Plitt, Guo-Xian Chen, Sandy Palmer, Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology. ,vol. 36, pp. 253- 262 ,(1989) , 10.1016/0166-6851(89)90173-4
Cally Roper, Richard Pearce, Shalini Nair, Brian Sharp, François Nosten, Tim Anderson, Intercontinental Spread of Pyrimethamine-Resistant Malaria Science. ,vol. 305, pp. 1124- 1124 ,(2004) , 10.1126/SCIENCE.1098876
Cally Roper, Richard Pearce, Barry Bredenkamp, Jonathan Gumede, Chris Drakeley, Frank Mosha, Daniel Chandramohan, Brian Sharp, Antifolate antimalarial resistance in southeast Africa: a population-based analysis. The Lancet. ,vol. 361, pp. 1174- 1181 ,(2003) , 10.1016/S0140-6736(03)12951-0
J. Straimer, N. F. Gnadig, B. Witkowski, C. Amaratunga, V. Duru, A. P. Ramadani, M. Dacheux, N. Khim, L. Zhang, S. Lam, P. D. Gregory, F. D. Urnov, O. Mercereau-Puijalon, F. Benoit-Vical, R. M. Fairhurst, D. Menard, D. A. Fidock, K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates Science. ,vol. 347, pp. 428- 431 ,(2015) , 10.1126/SCIENCE.1260867